Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.69 |
| ▸ | MEN1 | O00255 | 5/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | RAB9A | P51151 | 5/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | APP | P05067 | 1/20 | 0.69 |
| ▸ | INSR | P06213 | 1/20 | 0.69 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31063726 | 1.00 | MAPT (0.69) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL537849 | 1.00 | MAPT (0.69) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL319385 | 0.94 | MEN1 (0.77) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL319386 | 0.94 | MEN1 (0.77) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL29559249 | 0.94 | MEN1 (0.77) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| Dimethylamine SCHEMBL11573253 | 0.93 | MAPT (0.67) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL11776645 | 0.89 | MAPT (0.57) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL23111674 | 0.86 | MAPT (0.67) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL2628251 | 0.86 | MEN1 (0.67) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL6606615 | 0.86 | MEN1 (0.67) | MAPTMEN1KMT2ARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815000-B1 | Solid inks comprising liquid crystalline materials | XEROX CORPORATION (US) | 2014-08-26 | — | — | US | claimed |
| US-20140225956-A1 | SOLID INKS COMPRISING LIQUID CRYSTALLINE MATERIALS | XEROX CORPORATION (US) | 2014-08-14 | — | — | US | claimed |
| EP-2414355-A2 | FLUORESCENT CELLULAR MARKERS | Zayas, Beatriz (US) | 2012-02-08 | — | — | EP | claimed |
| WO-2010135751-A2 | FLUORESCENT CELLULAR MARKERS | BEATRIZ ZAYAS BEATRIZ (US) | 2010-11-25 | — | — | WO | claimed |
| US-20100256378-A1 | FLUORESCENT CELLULAR MARKERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-10-07 | — | — | US | claimed |
| US-4063894-A | CHROMOGEN, HYDROPEROXIDE, THIAZOLE | SHIONOGI & CO., LTD. (JA) | 1977-12-20 | — | — | US | claimed |
| JP-1161245-A | — | — | None | — | — | JP | disclosed |
| WO-2024240186-A1 | SULFUR-CONTAINING FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳博芮健制药有限公司 | 2024-11-28 | — | — | WO | disclosed |
| WO-2024200263-A1 | 2-STYRYLBENZOTHIAZOLE DERIVATIVES AS α-SYNUCLEIN BINDING COMPOUNDS | EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) | 2024-10-03 | — | — | WO | disclosed |
| EP-4438597-A1 | 2-STYRYLBENZOTHIAZOLE DERIVATIVES AS A-SYNUCLEIN BINDING COMPOUNDS | Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) | 2024-10-02 | — | — | EP | disclosed |
| WO-2024146597-A1 | PREPARATION METHOD FOR BENZOTHIAZOLE COMPOUND, AND INTERMEDIATE THEREOF | 上海博芮健制药有限公司 | 2024-07-11 | — | — | WO | disclosed |
| CN-117924166-A | Direct alkenylation of methylazaheteroaryl compounds and benzyl alcohols | 常州大学 | 2024-04-26 | — | — | CN | disclosed |
| US-11844846-B2 | Styrylbenzothiazole derivatives and uses in imaging methods | EMORY UNIVERSITY (US) | 2023-12-19 | — | — | US | disclosed |
| US-4880894-A | Quaternary ammonium salts used as phase transfer catalyst | ALTER, S.A. (ES) | 1989-11-14 | — | — | US | disclosed |
| JP-H01161245-A | ELECTROPHOTOGRAPHIC SENSITIVE BODY | CANON INC | 1989-06-23 | — | — | JP | disclosed |
| EP-0313221-A2 | Photostencils for screenprinting | AUTOTYPE INTERNATIONAL LIMITED (GB) | 1989-04-26 | — | — | EP | disclosed |
| EP-0267136-A2 | Quaternary ammonium salts used as phase transfer catalysts | ALTER, S.A. (ES) | 1988-05-11 | — | — | EP | disclosed |
| US-4063894-A | CHROMOGEN, HYDROPEROXIDE, THIAZOLE | SHIONOGI & CO., LTD. (JA) | 1977-12-20 | — | — | US | disclosed |
| US-3994724-A | SUBSTITUTED ANILINE PHOTOCONDUCTOR | SCOTT PAPER COMPANY (US) | 1976-11-30 | — | — | US | disclosed |
| US-3912697-A | Light-sensitive polymers | EASTMAN KODAK CO | 1975-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256378-A1 | FLUORESCENT CELLULAR MARKERS | AIFM1, CASP3, BAX | MAPT 3510/4885MEN1 2951/4885KMT2A 1656/4885 |
| US-11844846-B2 | Styrylbenzothiazole derivatives and uses in imaging methods | SNCA, NLN, SMN1; SMN2 | MAPT 38/4885MEN1 4073/4885KMT2A 3301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.